Astrana Health (ASTH) Return on Capital Employed (2011 - 2026)

Astrana Health (ASTH) has 16 years of Return on Capital Employed data on file, last reported at 1.05% in Q1 2026.

• Quarterly Return on Capital Employed fell 707.0% year-over-year to 1.05% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.05% (down 707.0% YoY) and the FY2025 annual result came in at 0.71%, down 1077.0% from the prior year.
• Return on Capital Employed advanced to 1.05% in Q1 2026 per ASTH's latest filing, from 0.52% in the prior quarter.
• The five-year high for Return on Capital Employed was 13.88% in Q1 2022, with the low at 0.52% in Q4 2025.
• Average Return on Capital Employed over 5 years is 9.61%, with a median of 10.78% recorded in 2023.
• Year-over-year, Return on Capital Employed surged 78 bps in 2023 and tumbled 884 bps in 2025.
• Astrana Health's Return on Capital Employed stood at 12.84% in 2022, then retreated by 16 bps to 10.78% in 2023, then dropped by 13 bps to 9.36% in 2024, then plunged by 94 bps to 0.52% in 2025, then surged by 104 bps to 1.05% in 2026.
• Business Quant data shows ASTH's Return on Capital Employed at 1.05% in Q1 2026, 0.52% in Q4 2025, and 5.03% in Q3 2025.